BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 23534055)

  • 1. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
    Kavalali ET; Monteggia LM
    Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
    Autry AE; Adachi M; Nosyreva E; Na ES; Los MF; Cheng PF; Kavalali ET; Monteggia LM
    Nature; 2011 Jun; 475(7354):91-5. PubMed ID: 21677641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does ketamine elicit a rapid antidepressant response?
    Kavalali ET; Monteggia LM
    Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.
    Monteggia LM; Gideons E; Kavalali ET
    Biol Psychiatry; 2013 Jun; 73(12):1199-203. PubMed ID: 23062356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
    Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
    Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A key requirement for synaptic Reelin signaling in ketamine-mediated behavioral and synaptic action.
    Kim JW; Herz J; Kavalali ET; Monteggia LM
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
    Kim JW; Monteggia LM
    Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition.
    Luscher B; Feng M; Jefferson SJ
    Adv Pharmacol; 2020; 89():43-78. PubMed ID: 32616214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
    Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF - a key transducer of antidepressant effects.
    Björkholm C; Monteggia LM
    Neuropharmacology; 2016 Mar; 102():72-9. PubMed ID: 26519901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.
    Duman RS; Shinohara R; Fogaça MV; Hare B
    Mol Psychiatry; 2019 Dec; 24(12):1816-1832. PubMed ID: 30894661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.
    Gideons ES; Kavalali ET; Monteggia LM
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8649-54. PubMed ID: 24912158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergence of distinct signaling pathways on synaptic scaling to trigger rapid antidepressant action.
    Suzuki K; Kim JW; Nosyreva E; Kavalali ET; Monteggia LM
    Cell Rep; 2021 Nov; 37(5):109918. PubMed ID: 34731624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
    Pham TH; Gardier AM
    Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.